Digirad posts Q3 results

10/22/2009 | EarthTimes.org

Digirad said it continues to achieve positive cash flow and improved gross margins in its imaging solutions unit for the third quarter ended Sept. 30. The company said it is on its way to gain positive net earnings for 2009 despite lower sales in nuclear gamma cameras. "We believe our new proprietary Cardius X-ACT imaging system, introduced earlier this year, is ideally suited for large volume nuclear medicine departments and practices. We believe that we are well positioned to grow our revenues and market share when the economic recovery begins," CEO Todd Clyde said.

View Full Article in:

EarthTimes.org

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA